Zydus Cadila gets final approval from the USFDA for Fluocinonide Cream

Source:  
https://www.indiainfoline.com/article/news-top-story/zydus-cadila-gets-final-approval-from-the-usfda-for-fluocinonide-cream-120021100502_1.html

The company said that the drug will be manufactured at the group's Topical manufacturing facility at Ahmedabad.

Zydus Cadila said on Tuesday that it has received the final approval from the USFDA to market Fluocinonide Cream USP, (US RLD - Vanos Cream) 0.1 %.
\
The drug is used to treat a variety of skin conditions (e.g., psoriasis, eczema, dermatitis, allergies, rash).

\\\
The company said that the drug will be manufactured at the group's Topical manufacturing facility at Ahmedabad.

The group now has 279 approvals and has so far filed over 386 ANDAs since the commencement of the filing process in FY2003-04, the company added.
Cadila Healthcare Ltd is currently trading at Rs274.35, down by Rs4.45 or 1.6% from its previous closing of Rs278.80 on the BSE.

The scrip opened at Rs279.90 and has touched a high and low of Rs279.90 and Rs273.10 respectively.